Filarial infection during pregnancy has profound consequences on immune response and disease outcome in children: A birth cohort study

BACKGROUND: Current Global Program to Eliminate Lymphatic Filariasis (GPELF) that prohibits pregnant mothers and children below two years of age from coverage targeted interruption of transmission after 5–6 rounds of annual mass drug administration (MDA). However, after more than 10 rounds of MDA in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bal, Madhusmita, Ranjit, Manoranjan, Satapathy, Ashok K., Khuntia, Hemant K., Pati, Sanghamitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173457/
https://www.ncbi.nlm.nih.gov/pubmed/30252839
http://dx.doi.org/10.1371/journal.pntd.0006824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173457/
https://www.ncbi.nlm.nih.gov/pubmed/30252839
http://dx.doi.org/10.1371/journal.pntd.0006824

Ejemplares similares